FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Real-time BOERSE MUENCHEN 03:16:49 27/05/2024 pm IST | ||
| 9.3 EUR | 0.00% |
|
| Current month | +0.11% | ||
| 1 month | +12.86% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 9.3 | 0.00% |
| 24/24/24 | 9.3 | -0.96% |
| 23/24/23 | 9.39 | -6.38% |
| 22/24/22 | 10.03 | -1.28% |
| 21/24/21 | 10.16 | -3.24% |
Real-time BOERSE MUENCHEN
Last update May 27, 2024 at 03:16 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36BU |
| ISIN | DE000HD36BU4 |
| Date issued | 28/02/2024 |
| Strike | 109 $ |
| Maturity | Unlimited |
| Parity | 11.18 : 1 |
| Emission price | 10.34 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.92 € |
|---|---|
| Lowest since issue | 7.36 € |
| Spread | 0.06 € |
| Spread % | 0.64% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
217.8
USD
Average target price
286.1
USD
Spread / Average Target
+31.33%
- Stock Market
- Certificates
- Certificat
